Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOFLOXACIN Cause Central nervous system lesion? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Central nervous system lesion have been filed in association with LEVOFLOXACIN (Levofloxacin). This represents 0.0% of all adverse event reports for LEVOFLOXACIN.

8
Reports of Central nervous system lesion with LEVOFLOXACIN
0.0%
of all LEVOFLOXACIN reports
1
Deaths
7
Hospitalizations

How Dangerous Is Central nervous system lesion From LEVOFLOXACIN?

Of the 8 reports, 1 (12.5%) resulted in death, 7 (87.5%) required hospitalization, and 2 (25.0%) were considered life-threatening.

Is Central nervous system lesion Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOFLOXACIN. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOFLOXACIN Cause?

Drug hypersensitivity (3,660) Neuropathy peripheral (2,619) Arthralgia (2,594) Pain in extremity (2,317) Pain (2,266) Drug ineffective (2,181) Dyspnoea (2,074) Tendonitis (1,813) Aortic aneurysm (1,767) Nausea (1,694)

What Other Drugs Cause Central nervous system lesion?

FINGOLIMOD (2,416) DIMETHYL (1,152) INTERFERON BETA-1A (978) NATALIZUMAB (627) DALFAMPRIDINE (561) GLATIRAMER (492) TERIFLUNOMIDE (315) ADALIMUMAB (229) OFATUMUMAB (185) RITUXIMAB (151)

Which LEVOFLOXACIN Alternatives Have Lower Central nervous system lesion Risk?

LEVOFLOXACIN vs LEVOKETOCONAZOLE LEVOFLOXACIN vs LEVOLEUCOVORIN LEVOFLOXACIN vs LEVOMEPROMAZINE LEVOFLOXACIN vs LEVOMETHADONE LEVOFLOXACIN vs LEVOMILNACIPRAN

Related Pages

LEVOFLOXACIN Full Profile All Central nervous system lesion Reports All Drugs Causing Central nervous system lesion LEVOFLOXACIN Demographics